{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:16:40Z","timestamp":1777515400167,"version":"3.51.4"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177043","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T19:22:49Z","timestamp":1494357769000},"page":"e0177043","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of chronic estradiol plus progesterone treatment on experimental arterial and venous thrombosis in mouse"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7557-6042","authenticated-orcid":true,"given":"Marie-C\u00e9cile","family":"Val\u00e9ra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Noirrit-Esclassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Buscato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Vinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeva","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Briaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lairez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coralie","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Payrastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Arnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1677\/joe.0.0480599","article-title":"Peripheral plasma progesterone concentration of cows during puberty, oestrous cycles, pregnancy and lactation, and the effects of under-nutrition or exogenous oxytocin on progesterone concentration","volume":"48","author":"LE Donaldson","year":"1970","journal-title":"J Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1210\/en.2012-1138","article-title":"Progesterone receptors: a key for neuroprotection in experimental stroke","volume":"153","author":"A Liu","year":"2012","journal-title":"Endocrinology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/eci.12447","article-title":"The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens","volume":"45","author":"S Salerni","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1172\/JCI200111374","article-title":"A complex role for the progesterone receptor in the response to vascular injury","volume":"108","author":"RH Karas","year":"2001","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"JE Rossouw","year":"2002","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.maturitas.2008.07.007","article-title":"Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review","volume":"60","author":"M L'Hermite","year":"2008","journal-title":"Maturitas"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"M Canonico","year":"2007","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"M Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"PY Scarabin","year":"2003","journal-title":"Lancet"},{"key":"ref10","first-page":"CD000402","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","author":"S Furness","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000360554","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women","volume":"43","author":"PY Scarabin","year":"2014","journal-title":"Front Horm Res"},{"issue":"Suppl 2","key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/13697137.2014.956717","article-title":"Hormones and venous thromboembolism among postmenopausal women","volume":"17","author":"PY Scarabin","year":"2014","journal-title":"Climacteric"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"FZ Stanczyk","year":"2014","journal-title":"Endocr Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.maturitas.2015.06.040","article-title":"Hormone therapy and risk of venous thromboembolism among postmenopausal women","volume":"82","author":"M Canonico","year":"2015","journal-title":"Maturitas"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2012-01-405498","article-title":"Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor alpha","volume":"120","author":"MC Valera","year":"2012","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1210\/en.2012-2059","article-title":"The AF-1 activation function of estrogen receptor alpha is necessary and sufficient for uterine epithelial cell proliferation in vivo","volume":"154","author":"A Abot","year":"2013","journal-title":"Endocrinology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.1073\/pnas.1322057111","article-title":"Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions","volume":"111","author":"M Adlanmerini","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/jsm.12127","article-title":"Vaginal lubrication after cervicovaginal stimulation is facilitated by phosphodiesterase type 5 inhibition in ovariectomized mice","volume":"10","author":"X Game","year":"2013","journal-title":"J Sex Med"},{"key":"ref19","article-title":"Mouse complete stasis model of inferior vena cava thrombosis","author":"SK Wrobleski","year":"2011","journal-title":"J Vis Exp"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/me.2008-0044","article-title":"Rapid recruitment of temporally distinct vascular gene sets by estrogen","volume":"22","author":"KK Schnoes","year":"2008","journal-title":"Mol Endocrinol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jth.12510","article-title":"Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH","volume":"12","author":"J Geddings","year":"2014","journal-title":"J Thromb Haemost"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.180.6.3661","article-title":"Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production","volume":"180","author":"V Douin-Echinard","year":"2008","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/j.1476-5381.2009.00470.x","article-title":"Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice","volume":"158","author":"T Freudenberger","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"Suppl 3","key":"ref24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.fertnstert.2004.05.069","article-title":"Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice","volume":"82","author":"JM Shultz","year":"2004","journal-title":"Fertil Steril"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/9780470942390.mo140140","article-title":"Ferric chloride-induced arterial thrombosis in mice","volume":"4","author":"S Subramaniam","year":"2014","journal-title":"Curr Protoc Mouse Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"497841","DOI":"10.1155\/2011\/497841","article-title":"Animal models of cardiovascular diseases","volume":"2011","author":"C Zaragoza","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1111\/bph.12814","article-title":"Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice","volume":"171","author":"T Freudenberger","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"ref28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/13697137.2013.808563","article-title":"HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT","volume":"16","author":"M L'Hermite","year":"2013","journal-title":"Climacteric"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm0397-324","article-title":"Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm","volume":"3","author":"K Miyagawa","year":"1997","journal-title":"Nat Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1073\/pnas.94.12.6535","article-title":"Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium","volume":"94","author":"PS Cooke","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2005.05.003","article-title":"New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits","volume":"52","author":"MG Modena","year":"2005","journal-title":"Maturitas"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"E Hoibraaten","year":"2001","journal-title":"Br J Haematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T01:06:23Z","timestamp":1719191183000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177043"}},"subtitle":[],"editor":[{"given":"Christian","family":"Schulz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177043","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}